使用UHPLC-Q-Orbitrap MS对大鼠血中甲胺的有效量化用于药理动力学分析
1Department of Pharmacy, The First People's Hospital of Kerqin District, Tongliao, 028000, China. starking2019888@163.com.
Analytical methods : advancing methods and applications
|January 26, 2026
概括
一种新的超高性能液态色谱四极管轨道质谱法准确地量化了血中的甲胺. 这种经过验证的测定对于理解格洛科马治疗中甲胺的药理动力学至关重要.
科学领域:
- 分析化学 分析化学
- 药理动力学 药理动力学
- 质谱测量质量谱测量
背景情况:
- 甲胺是一种碳酸酶抑制剂,用于治疗各种类型的玻璃眼瘤并降低眼内压力.
- 在等离子体等生物矩阵中精确量化甲胺对于药理动力学研究和治疗药物监测至关重要.
- 现有的方法可能缺乏对综合性药理动力学分析所需的灵敏度,选择性或效率.
研究的目的:
- 开发和验证一种高度选择性和敏感的分析方法,用于在血中量化甲胺.
- 在临床前研究中建立一个可靠的方法来评估甲胺胺的药理动力学.
- 为未来对甲胺的临床药理动力学研究提供可靠的工具.
主要方法:
- 使用超高性能液体色谱与四极-轨道轨道质谱学 (UHPLC-Q-Orbitrap MS) 结合使用.
- 通过使用BEH Shield RP18柱实现了分离,其中使用了氨和含酸的水的梯度化.
- 检测是在正离子化模式下进行的,使用完整的MS/dd-MS2获取.
主要成果:
- 该方法表现出了出色的选择性和灵敏性,其下限量化值为10μg L-1.1.
- 对中胺在血中的广泛线性相关性范围 (105000μg L-1) 已建立.
- 实现了高精度和准确性 (低于8%) 和高效的提取回收 (86.1696.06%).
结论:
- 已成功建立了一种经过验证,灵敏和选择性的UHPLC-Q-Orbitrap MS方法,用于在血中定量甲胺.
- 该方法适用于药理动力学研究,正如其应用于大鼠血样本所证明的那样.
- 这种分析方法为评估甲胺在生物系统中的行为提供了一种有效的手段.
相关概念视频
Analysis of Population Pharmacokinetic Data
698
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
698
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
441
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
441
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
330
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
330
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
522
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
522
Pharmacokinetics: Overview
9.4K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.4K
Pharmacokinetic Models: Overview
2.0K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.0K


